Tsevat J, Weinstein M C, Williams L W, Tosteson A N, Goldman L
Department of Medicine, Beth Israel Hospital, Boston, MA.
Circulation. 1991 Apr;83(4):1194-201. doi: 10.1161/01.cir.83.4.1194.
Despite much evidence that modifying risk factors for coronary heart disease can decrease morbidity and mortality, little is known about the impact of risk-factor modification on life expectancy.
We used the Coronary Heart Disease Policy Model, a state-transition computer simulation of the US population, to forecast potential gains in life expectancy from risk-factor modification for the cohort of Americans turning age 35 in 1990. Among 35-year-old men, we projected that the population-wide increase in life expectancy would be about 1.1 years from strict blood pressure control, 0.8 years from smoking cessation, 0.7 years from reduction of serum cholesterol to 200 mg/dl, and about 0.6 years from weight loss to ideal body weight. For women, reducing cholesterol to 200 mg/dl would have the greatest estimated impact-a gain of 0.8 years-whereas smoking cessation, blood pressure control, or weight loss would yield population-wide gains of 0.7, 0.4, and 0.4 years, respectively. Gains for 35-year-old individuals having a given risk factor are greater. We estimate that, on average, male smokers would gain 2.3 years from quitting smoking; males with hypertension would gain 1.1-5.3 years from reducing their diastolic blood pressure to 88 mm Hg; men with serum cholesterol levels exceeding 200 mg/dl would gain 0.5-4.2 years from lowering their serum cholesterol level to 200 mg/dl; and overweight men would gain an average of 0.7-1.7 years from achieving ideal body weight. Corresponding projected gains for at-risk women are 2.8 years from quitting smoking, 0.9-5.7 years from lowering blood pressure, 0.4-6.3 years from decreasing serum cholesterol, and 0.5-1.1 years from losing weight. Eliminating coronary heart disease mortality is estimated to extend the average life expectancy of a 35-year-old man by 3.1 years and a 35-year-old woman by 3.3 years.
Population-wide gains in life expectancy from single risk-factor modifications are modest, but gains to individuals at risk can be more substantial.
尽管有大量证据表明,改变冠心病的危险因素可降低发病率和死亡率,但对于改变危险因素对预期寿命的影响却知之甚少。
我们使用冠心病政策模型(一种对美国人群进行状态转换的计算机模拟模型),来预测1990年满35岁的美国人通过改变危险因素在预期寿命方面可能获得的收益。在35岁男性中,我们预计,从严格控制血压来看,全人群预期寿命将增加约1.1年;从戒烟来看,预期寿命将增加0.8年;从将血清胆固醇降至200mg/dl来看,预期寿命将增加0.7年;从减重至理想体重来看,预期寿命将增加约0.6年。对于女性而言,将胆固醇降至200mg/dl预计影响最大,预期寿命增加0.8年,而戒烟、控制血压或减重分别使全人群预期寿命增加0.7年、0.4年和0.4年。对于有特定危险因素的35岁个体,收益更大。我们估计,平均而言,男性吸烟者戒烟可使预期寿命增加2.3年;患有高血压的男性将舒张压降至88mmHg可使预期寿命增加1.1 - 5.3年;血清胆固醇水平超过200mg/dl的男性将血清胆固醇水平降至200mg/dl可使预期寿命增加0.5 - 4.2年;超重男性达到理想体重可使预期寿命平均增加0.7 - 1.7年。有风险的女性相应的预期收益为:戒烟可增加2.8年,降低血压可增加0.9 - 5.7年,降低血清胆固醇可增加0.4 - 6.3年,减重可增加0.5 - 1.1年。据估计,消除冠心病死亡可使35岁男性的平均预期寿命延长3.1年,使35岁女性的平均预期寿命延长3.3年。
通过单一危险因素改变实现的全人群预期寿命增加幅度不大,但对有风险的个体而言,收益可能更大。